Relay Medical congratulates Glow LifeTech Corp. for its registration with the CSE underneath the image “GLOW”
Toronto, Ontario – (Newsfile Corp. – March 15, 2021) – Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) (“Relay“or the”Enterprise“) want to congratulate Glow LifeTech Corp (“Shine“) for its latest itemizing on the Canadian Securities Trade (” CSE “). Glow started buying and selling on the CSE right this moment underneath the image” GLOW “.
Relay is a founding shareholder of Glow and just lately added to his place by taking part in Glow’s RTO funding on February 9, 2021, which was oversubscribed at over $ 5.1 million raised. Glow has benefited from Relay’s infrastructure, technical experience and enterprise management for analysis, testing and product validation of Glow’s revolutionary expertise.
Toronto-based Glow is a biotechnology firm targeted on feeding the subsequent era of pure well being merchandise with extremely efficient, science-backed pure substances. Glow produces nutraceutical and cannabinoid-based merchandise with dramatically improved bioavailability, absorption and efficacy due to its revolutionary natural MyCell.TM Expertise supply system.
“Relay may be very proud to see Glow take this essential step and develop into its personal public firm,” stated Yoav Raiter, CEO of Relay Medical Corp. they’re properly positioned to disrupt the market with merchandise like their just lately introduced ArtemiCTM which has proven promising scientific trial outcomes with sufferers with COVID-19. “
Glow just lately introduced that it has obtained the unique gross sales and distribution rights in North America and the Caribbean for ArtemiC ™, a pure well being product primarily based on Glow’s MyCell ™ expertise which just lately reported profitable outcomes from a scientific trial. part II COVID-19 (see Relay press launch of January 14, 2021).
For extra data on Glow, contact email@example.com or subscribe to their mailing checklist at https://www.glowlifetech.com/information.
SUBSCRIBE: For extra data on Relay or to subscribe to the corporate’s mailing checklist, go to: https://www.relaymedical.com/information.
About Glow LifeTech
Glow LifeTech is a Canada-based biotechnology firm targeted on the manufacturing of nutraceutical and cannabinoid merchandise with dramatically improved bioavailability, absorption and efficacy. Glow owns the rights to the revolutionary natural MyCellTM Expertise supply system, which transforms poorly absorbed pure compounds into improved concentrates suitable with water, thus unleashing the complete therapeutic potential of pure energetic compounds.
Web site: www.glowlifetech.com
About Relay Medical Corp.
Relay Medical is a expertise developer and innovator headquartered in Toronto, Canada, targeted on the event of recent applied sciences within the diagnostic and knowledge science sectors of AI.
Web site: www.relaymedical.com
W. Clark Kent
Relay Medical Corp.
Workplace. 647-872-9982 ext. 2
TF. 1-844-247-6633 ext. 2
Investor Relations within the EU
Workplace. +49 (0) 177 774 2314
Cautionary Assertion Relating to Ahead-Wanting Info
Aside from statements of historic truth, this press launch comprises sure “forward-looking data” throughout the which means of relevant securities legal guidelines. Ahead-looking data is ceaselessly characterised by phrases equivalent to “plan”, “count on”, “plan”, “intend”, “imagine”, “anticipate”, “estimate” and different related phrases, or statements that sure occasions or circumstances “could” or “will” happen. Ahead-looking statements are primarily based on opinions and estimates as of the date the statements are made, and are topic to quite a lot of dangers and uncertainties and different elements that might trigger precise occasions or outcomes to happen. differ considerably from these anticipated within the forecasts. statements, together with, however not restricted to, delays or uncertainties with regulatory approvals, together with that of the CSE. There are uncertainties inherent in forward-looking data, together with elements past the management of the corporate. There might be no assurance that the plans to commercialize the expertise described on this press launch will probably be efficient on the phrases or for the interval described on this press launch. The Firm assumes no obligation to replace forward-looking data if circumstances or administration’s estimates or opinions change, besides as required by regulation. The reader is cautioned to not place undue reliance on forward-looking statements. Further data figuring out the dangers and uncertainties that might have an effect on the monetary outcomes is contained within the paperwork filed by the Firm with the Canadian securities regulators, which can be found on the following handle: www.sedar.com
To view the supply model of this press launch, please go to https://www.newsfilecorp.com/launch/77283